Home » Topics » BioWorld Science

BioWorld Science
RSS

Completed phase I studies of ME-3183 pave way for phase II studies in plaque psoriasis

Aug. 24, 2021

Bristol Myers Squibb identifies new lead BRD4 inhibitors

Aug. 24, 2021

Phase IIb study of izencitinib in ulcerative colitis misses primary endpoint

Aug. 24, 2021

First-in-human data reported for [68Ga]iPSMA-BN in healthy subjects

Aug. 24, 2021

Foghorn initiates first-in-human study of FHD-609 for synovial sarcoma

Aug. 24, 2021

H3.3-K27M drives tumorigenesis in hindbrain NSCs through disruption of PRC2 and enhancer functions

Aug. 24, 2021

Small-molecule degrader targets phospho-AKT and inhibits growth of PI3K/PTEN pathway mutant cancers

Aug. 24, 2021

New delivery system SENDs therapeutic RNA without triggering immune system

Aug. 24, 2021

Rhenium-labeled nanoliposomes show efficacy in rat models of leptomeningeal disease

Aug. 24, 2021

Suzhou Ark Biopharmaceutical patents respiratory syncytial virus inhibitors

Aug. 24, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Neuro deals aplenty: UCB’s $1B+ takeover of Neurona the latest
BioWorld
A flurry of deals focused on the neurological disease space in 2026 suggest large biopharma companies are searching for the next best therapeutics for everything...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...